Fingerprint
Dive into the research topics of 'Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer
Tomohisa Otsu, Yoshikuni Inokawa*, Hideki Takami, Masamichi Hayashi, Keisuke Kurimoto, Nobutake Tanaka, Haruyoshi Tanaka, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Yasuhiro Kodera
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations